Matribhumi Samachar English
Jupiter, Florida–(Newsfile Corp. – April 13, 2026) – Jupiter Neurosciences, Inc. (NASDAQ: JUNS), a clinical-stage pharmaceutical company developing JOTROL™, a patented resveratrol-based platform, will present at the Centri Capital Conference on Tuesday, April 14 at Nasdaq in New York City. Christer Rosén, Chairman and CEO will discuss the Company’s recent …
Read More »Jupiter Neurosciences to Participate in NobleCon21
Jupiter, Florida–(Newsfile Corp. – December 2, 2025) – Jupiter Neurosciences, Inc. (NASDAQ: JUNS), a clinical-stage pharmaceutical company developing JOTROL™, a patented resveratrol-based therapeutic platform targeting neuroinflammation and mitochondrial dysfunction, today announced that its management team will present at the upcoming Noble Capital Markets’ 21st Annual Emerging Growth Equity Conference on …
Read More »